Bausch Health Companies Turns To Profit In Q3; Stock Up In After-hours

(RTTNews) - Bausch Health Companies Inc. (BHC, BHC.TO) reported that its net income attributable to the company for the third quarter of 2025 was $179 million or $0.48 per share, compared to net loss of $85 million or $0.23 per share for the third quarter of 2024, an increase of $264 million.

BHC closed Wednesday's regular trading at $5.90 down $0.29 or 4.68%. But in the after-hours trading the stock gained $0.43 or 7.29%.

Consolidated adjusted net income attributable to the company for the third quarter of 2025 was $434 million, compared with $415 million for the third quarter of 2024, an increase of $19 million, primarily due to an increase in contribution and lower selling, general, and administrative expense, partially offset by higher interest expense.

Total consolidated reported revenues were $2.68 billion for the third quarter of 2025, compared with $2.51 billion in the third quarter of 2024, an increase of $171 million, or 7%. Excluding the impact of foreign exchange of $29 million, acquisitions of $3 million, and divestitures and discontinuations which negatively impacted the prior year by $3 million, revenue increased 5% on an organic1 basis compared with the third quarter of 2024.

Analysts expected the company to report earnings of $1.06 per share and revenues of $2.63 billion for the third quarter. Analysts' estimates typically exclude special items.

The company raised full-year 2025 revenue, Adjusted EBITDA, and Adjusted Cash Flow from Operations guidance.

The company now expects annual revenues to be in the range of $10.050 billion - $10.250 billion. Analysts expect revenue of $10.12 billion for the year.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.